Prion protein (PrPc) promotes β-amyloid plaque formation

被引:76
作者
Schwarze-Eicker, KA
Keyvani, K
Görtz, N
Westaway, D
Sachser, N
Paulus, W
机构
[1] Univ Hosp Munster, Inst Neuropathol, D-48129 Munster, Germany
[2] Univ Munster, Dept Behav Biol, D-4400 Munster, Germany
[3] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada
关键词
Alzheimer's disease; amyloid-beta plaques; prion protein; transgenic mouse;
D O I
10.1016/j.neurobiolaging.2004.10.004
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Prion protein (PrP) has been localized to amyloid-beta (A beta) senile plaques in aging and Alzheimer disease, but it is unknown whether PrP is directly involved in plaque formation or represents a reaction to amyloid deposition. To evaluate possible functional effects of PrP in A beta plaque formation, we analyzed bigenic mice (TgCRND8/Tg7), carrying mutant human amyloid precursor protein (APP) 695 (APP(swed + Ind), TgCRND8) as well as the wild-type Syrian hamster prion protein gene (sHaPrP, Tg7), showing A beta plaques at 3 months of age as well as highly increased HaPrP(c) levels. Compared to the control group, consisting of animals carrying only mutant APP, bigenic mice showed a higher number of senile plaques in the cerebral cortex, while APP transcription and A beta 40/A beta 42 levels were unchanged. Double-labelling immunofluorescence showed co-localization of A beta and PrP in virtually all plaques in the brains of both control and experimental animals. Our data suggest that PrP promotes plaque formation, and that this hitherto unknown functional role of PrP appears to be mediated by increased A beta aggregation rather than by altered APP transcription or processing. (c) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1177 / 1182
页数:6
相关论文
共 32 条
[1]   Games played by rogue proteins in prion disorders and Alzheimer's disease [J].
Aguzzi, A ;
Haass, C .
SCIENCE, 2003, 302 (5646) :814-818
[2]  
[Anonymous], 2011, NEURODEGENERATION MO
[3]   Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice [J].
Bayer, TA ;
Schäfer, S ;
Simons, A ;
Kemmling, A ;
Kamer, T ;
Tepest, R ;
Eckert, A ;
Schüssel, K ;
Eikenberg, O ;
Sturchler-Pierrat, C ;
Abramowski, D ;
Staufenbiel, M ;
Multhaup, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14187-14192
[4]   Polymorphism of the codon 129 of the prion protein (PrP) gene and neuropathology of cerebral ageing [J].
Berr, C ;
Helbecque, N ;
Sazdovitch, V ;
Mohr, M ;
Amant, C ;
Amouyel, P ;
Alpérovitch, A ;
Hauw, JJ .
ACTA NEUROPATHOLOGICA, 2003, 106 (01) :71-74
[5]   Spongiform encephalopathies - B lymphocytes and neuroinvasion [J].
Brown, P .
NATURE, 1997, 390 (6661) :662-663
[6]   Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators [J].
Checler, F ;
Vincent, B .
TRENDS IN NEUROSCIENCES, 2002, 25 (12) :616-620
[7]   Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 [J].
Chishti, MA ;
Yang, DS ;
Janus, C ;
Phinney, AL ;
Horne, P ;
Pearson, J ;
Strome, R ;
Zuker, N ;
Loukides, J ;
French, J ;
Turner, S ;
Lozza, G ;
Grilli, M ;
Kunicki, S ;
Morissette, C ;
Paquette, J ;
Gervais, F ;
Bergeron, C ;
Fraser, PE ;
Carlson, GA ;
St George-Hyslop, P ;
Westaway, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) :21562-21570
[8]   Cellular prion protein ablation impairs behavior as a function of age [J].
Coitinho, AS ;
Roesler, R ;
Martins, VR ;
Brentani, RR ;
Izquierdo, I .
NEUROREPORT, 2003, 14 (10) :1375-1379
[9]   Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases [J].
Esiri, MM ;
Carter, J ;
Ironside, JW .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2000, 26 (03) :273-284
[10]  
Ferrer I, 2001, ACTA NEUROPATHOL, V101, P49